HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced it has been named to the Forbes 2012 100 Most Trustworthy Companies. The list, compiled by independent financial analytics company GMI Ratings, was a quantitative and qualitative analysis of companies’ accounting and governance risk, looking at a variety of factors related to corporate accounting, governance and management practices.
